Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Cancer (2)
- AK549 (1)
- Antibody-Drug Conjugate (1)
- Arab American (1)
- B7H3 (1)
-
- BCL-XL (1)
- Breast cancer (1)
- Breast cancer screening (1)
- Chaplain (1)
- Cisplatin (1)
- Colorectal cancer (1)
- Colorectal cancer screening (1)
- FLASH (1)
- FLASH Radiation (1)
- GBM (1)
- Lung Cancer (1)
- NSCLC (1)
- Palliative care (1)
- Platinum (1)
- Platinum Sensitizer (1)
- Preventative (1)
- Radiation (1)
- Senescence (1)
- Sensitization (1)
- Sensitizer (1)
- Spiritual care (1)
- Publication
- Publication Type
- File Type
Articles 1 - 4 of 4
Full-Text Articles in Medicine and Health Sciences
Effects Of Chaplain Care On Coping With Cancer, Sarah Battiston, Scott L. Baughan
Effects Of Chaplain Care On Coping With Cancer, Sarah Battiston, Scott L. Baughan
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical case decision report using:
Piderman KM, Radecki CR, Jenkins SM, et al. Hearing and heeding the voices of those with advanced illnesses. Journal of Palliative Care. 2020;35(4):248-255. https://doi.org/10.1177/0825859720928623
for a patient having difficulty coping with cancer
Breast Cancer And Colorectal Cancer Screening In Arab Americans From 2021-2023, Nicole Oska, Hasti Nema, Deni Peterson, Kendall Brothers, Mohammed Najeeb Al Hallek
Breast Cancer And Colorectal Cancer Screening In Arab Americans From 2021-2023, Nicole Oska, Hasti Nema, Deni Peterson, Kendall Brothers, Mohammed Najeeb Al Hallek
Medical Student Research Symposium
Breast Cancer and Colorectal Cancer Screening in Arab Americans from 2021-2023
Nicole Oska1, Hasti Nema1, Deni Peterson1, Kendall Brothers1, Mohammed Najeeb Al Hallak1,2
1Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, USA; 2Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA
Introduction:
Breast cancer (BC) and colorectal cancer (CRC) are among the most commonly diagnosed cancers in the United States1,2; screening for these cancers is a pivotal component of preventative healthcare. Arab Americans represent a diverse, yet understudied, patient population that may encounter distinct barriers …
Flash Radiation Ultra-High Dose Rate Radiation With Potential For Sensitization By Platinum, Abigail A. Jaczkowski, Stephen Brown Ph.D.
Flash Radiation Ultra-High Dose Rate Radiation With Potential For Sensitization By Platinum, Abigail A. Jaczkowski, Stephen Brown Ph.D.
Medical Student Research Symposium
External beam radiation therapy, a cornerstone in cancer treatment for 50% of patients, poses challenges due to its toxicity to both cancer and healthy cells. Seeking to mitigate side effects, the emerging FLASH radiation technology employs ultra-high dose rates, promising quicker treatments with reduced impact on surrounding normal tissue. Platinum, recognized as a radiation sensitizer, enhances the effectiveness of radiation therapy by increasing sensitization at higher energy levels through pair-production.
This study explores the hypothesis that Cisplatin, a platinum-based chemotherapy agent, will exhibit a synergistic effect when combined with FLASH radiation. Using A549 cells from non-small cell lung cancer, the …
Analysis Of Antibody Drug Conjugate On Cellular Senescent Human Glioblastoma, Ariel P. Walker, Renee Hirte, Cecile Riviere-Cazaux, Authur Warrington, Terry Burns
Analysis Of Antibody Drug Conjugate On Cellular Senescent Human Glioblastoma, Ariel P. Walker, Renee Hirte, Cecile Riviere-Cazaux, Authur Warrington, Terry Burns
Medical Student Research Symposium
Background: Glioblastoma Multiforme (GBM) is an aggressive and malignant brain tumor known for its rapid progression and unfavorable prognosis. The standard treatment options primarily involve radiation and temozolomide, however recurrence is inevitable.
B7H3/CD276, an immunomodulatory transmembrane glycoprotein, demonstrates tumor-specific expression, with limited presence in normal healthy tissue, making it a promising and attractive treatment target in GBM. AbbV155 is an antibody drug conjugate that inhibits BCL-XL and specifically targets B7H3 (CD276) on GBM cells with the goal of selectively eliminating viable tumor cells.
Objectives: First, we sought to confirm the presence of B7H3/CD276 in our selected cell line via …